References
- Liddle G W, Heissel R M, McKenzie J M. Graves' disease without hyperthyroidism. Am J Med. 1965; 39: 845–849
- Hall R, Doniach D, Kirkhama K, Kabir D E. Ophthalmic Graves' disease. Lancet. 1970; 22: 375–378
- Solomon D H, Chopra I J, Choprd V, Smith F J. Identification of subgroups of euthyroid Graves' ophthalmopathy. N Engl J Med. 1977; 296: 181–186
- Franco P S, Hershman J M, Haigler E D, Pittman J A. Responses to thyrotropin‐releasing hormone compared with thyroid suppression tests in euthyroid Graves' disease. Metabolism. 1973; 22: 1357–1365
- Teng C S, Smith B R, Clayton B, Evered D C, Clarck F, Hall R. Thyroid‐stimulating immunoglobulins in ophthalmic Graves' disease. Clin Endocrinol. 1977; 6: 207–211
- Tomai H, Nakagawa T, Ohsako N, Fukimo O, Takahashi S. Changes in thyroid function in patients with euthyroid Graves' disease. J Clin Endocrinol Metab. 1980; 50: 108–112
- Wall J R. Immunological aspects of Graves' ophthalmopathy. The Eye and Orhit in Thyrord Disease, C Gorman, R Walter, J Dyer. Raven Press, New York 1974; 103–119
- Jacobson D H, Gorman C A. Endocrine ophthalmopathy: Current ideas concerning etiology pathogenesis and treatment. Endocr Rev. 1984; 5: 200–220
- Kendall‐Taylor P, Jones D, Weightman D, Atkinson S. The diagnostic value of antibody test in Graves' ophthalmopathy. Akt Endokr Stoffw. 1988; 9: 30–32
- Kasagi K, Hataby H, Tokuda Y, Iida Y, Endo K, Konishi H. Studies on thyrotropin receptor antibodies in patients with euthyroid Graves' disease. Clin Endocrinal. 1988; 29: 357–366
- Marcocci C, Bartalena L, Bogazzi F, Panicucci M, Pinchera A. Studies on the occurrence of ophthalmopathy in Graves' disease. Acta Endocrinol (Co‐penh) 1989; 120: 473–478
- Salvi M, Zhang Z G, Haegert D, Woo M, Liberman A, Cadarso L, Wall J R. Patients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalities. J Clin Endocrinol Metab. 1990; 70: 89–94
- Zhang Z ‐G, Medeiros‐Neto G, Iacona A, Lima N, Hiromatzu Y, Salvi M, Triller H, Bernard N, Wall J R. Studies of cytotoxic activities against eye muscle antigens in patients with thyroid‐associated ophthalmopathy. Acta Endocrinol. 1989; 121(supl. 2)23–30
- Hiromatsu Y, Fukazawa H, Guinard F, Salvi M, How J, Wall J R. A thyroid cytotoxic antibody that cross‐reacts with an eye muscle cell surface antigen may be the cause of thyroid‐associated ophthalmopathy. J Clin Endocrinol Metab. 1988; 67: 565–570
- Dillon J, Zhang Z ‐G, Hiromatsu Y, Bernard Y, Salvi M, Wall J R. Failure to detect complement mediated antibody dependent cytotoxicity against human orbital tissue cells in the serum of patients with thyroid‐associated ophthalmopathy. Autoimmunity. 1989; 5: 125–132
- Salvi M, Fukazawa H, Hiromatsu Y, et al. Role of autoanti‐bodies in the pathogenesis and association of endocrine autoimmune disorders. Endocr Rev. 1988; 9: 450–466
- Medeiros‐Neto G A. Laboratory evaluation in iodine deficiency disorders. Arq Bras Endocr Metab. 1984; 28: 100–106
- Burgi V, Scazziga B R, Rosselet P O, Burgi H, Studer H. Can serum thyroglobulin predict the effect of thyroid hormone therapy on goitre growth?. Acta Endocrinol. 1988; 119: 118–124